Global Chronic Kidney Disease (CKD) Treatment Market Research Report 2022

Publisher Name :
Date: 13-Apr-2022
No. of pages: 95
Inquire Before Buying

Chronic Kidney Disease (CKD) Treatment market is segmented by players, region (country), by Type and by Application. Players, stakeholders, and other participants in the global Chronic Kidney Disease (CKD) Treatment market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application for the period 2017-2028.

Segment by Type

- Medicine

- Hemodialysis

- Peritoneal Dialysis

- Kidney Transplantation

Segment by Application

- Hospitals

- Kidney Dialysis Centers

- At Homes

- Others

By Region

- North America

- - United States

- - Canada

- Europe

- - Germany

- - France

- - UK

- - Italy

- - Russia

- - Nordic Countries

- - Rest of Europe

- Asia-Pacific

- - China

- - Japan

- - South Korea

- - Southeast Asia

- - India

- - Australia

- - Rest of Asia

- Latin America

- - Mexico

- - Brazil

- - Rest of Latin America

- Middle East & Africa

- - Turkey

- - Saudi Arabia

- - UAE

- - Rest of MEA

By Company

- Fresenius

- DaVita

- Baxter

- Nipro

- B. Braun

- Asahi Kasei

- Nikkiso

- WEGO

- Newsol

- Mayo Clinic

- Guangdong Biolight

- Medtronic

- Sanxin Medtec

- Jafron Biomedical

- SWS Hemodialysis Care

- Tianyi Medical

- AstraZeneca

- Vifor Pharma

Global Chronic Kidney Disease (CKD) Treatment Market Research Report 2022

Table of Contents
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Chronic Kidney Disease (CKD) Treatment Market Size Growth Rate by Type: 2017 VS 2021 VS 2028
1.2.2 Medicine
1.2.3 Hemodialysis
1.2.4 Peritoneal Dialysis
1.2.5 Kidney Transplantation
1.3 Market by Application
1.3.1 Global Chronic Kidney Disease (CKD) Treatment Market Share by Application: 2017 VS 2021 VS 2028
1.3.2 Hospitals
1.3.3 Kidney Dialysis Centers
1.3.4 At Homes
1.3.5 Others
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Chronic Kidney Disease (CKD) Treatment Market Perspective (2017-2028)
2.2 Chronic Kidney Disease (CKD) Treatment Growth Trends by Region
2.2.1 Chronic Kidney Disease (CKD) Treatment Market Size by Region: 2017 VS 2021 VS 2028
2.2.2 Chronic Kidney Disease (CKD) Treatment Historic Market Size by Region (2017-2022)
2.2.3 Chronic Kidney Disease (CKD) Treatment Forecasted Market Size by Region (2023-2028)
2.3 Chronic Kidney Disease (CKD) Treatment Market Dynamics
2.3.1 Chronic Kidney Disease (CKD) Treatment Industry Trends
2.3.2 Chronic Kidney Disease (CKD) Treatment Market Drivers
2.3.3 Chronic Kidney Disease (CKD) Treatment Market Challenges
2.3.4 Chronic Kidney Disease (CKD) Treatment Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Chronic Kidney Disease (CKD) Treatment Players by Revenue
3.1.1 Global Top Chronic Kidney Disease (CKD) Treatment Players by Revenue (2017-2022)
3.1.2 Global Chronic Kidney Disease (CKD) Treatment Revenue Market Share by Players (2017-2022)
3.2 Global Chronic Kidney Disease (CKD) Treatment Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Chronic Kidney Disease (CKD) Treatment Revenue
3.4 Global Chronic Kidney Disease (CKD) Treatment Market Concentration Ratio
3.4.1 Global Chronic Kidney Disease (CKD) Treatment Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Chronic Kidney Disease (CKD) Treatment Revenue in 2021
3.5 Chronic Kidney Disease (CKD) Treatment Key Players Head office and Area Served
3.6 Key Players Chronic Kidney Disease (CKD) Treatment Product Solution and Service
3.7 Date of Enter into Chronic Kidney Disease (CKD) Treatment Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Chronic Kidney Disease (CKD) Treatment Breakdown Data by Type
4.1 Global Chronic Kidney Disease (CKD) Treatment Historic Market Size by Type (2017-2022)
4.2 Global Chronic Kidney Disease (CKD) Treatment Forecasted Market Size by Type (2023-2028)
5 Chronic Kidney Disease (CKD) Treatment Breakdown Data by Application
5.1 Global Chronic Kidney Disease (CKD) Treatment Historic Market Size by Application (2017-2022)
5.2 Global Chronic Kidney Disease (CKD) Treatment Forecasted Market Size by Application (2023-2028)
6 North America
6.1 North America Chronic Kidney Disease (CKD) Treatment Market Size (2017-2028)
6.2 North America Chronic Kidney Disease (CKD) Treatment Market Size by Country (2017-2022)
6.3 North America Chronic Kidney Disease (CKD) Treatment Market Size by Country (2023-2028)
6.4 United States
6.5 Canada
7 Europe
7.1 Europe Chronic Kidney Disease (CKD) Treatment Market Size (2017-2028)
7.2 Europe Chronic Kidney Disease (CKD) Treatment Market Size by Country (2017-2022)
7.3 Europe Chronic Kidney Disease (CKD) Treatment Market Size by Country (2023-2028)
7.4 Germany
7.5 France
7.6 U.K.
7.7 Italy
7.8 Russia
7.9 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Chronic Kidney Disease (CKD) Treatment Market Size (2017-2028)
8.2 Asia-Pacific Chronic Kidney Disease (CKD) Treatment Market Size by Country (2017-2022)
8.3 Asia-Pacific Chronic Kidney Disease (CKD) Treatment Market Size by Country (2023-2028)
8.4 China
8.5 Japan
8.6 South Korea
8.7 Southeast Asia
8.8 India
8.9 Australia
9 Latin America
9.1 Latin America Chronic Kidney Disease (CKD) Treatment Market Size (2017-2028)
9.2 Latin America Chronic Kidney Disease (CKD) Treatment Market Size by Country (2017-2022)
9.3 Latin America Chronic Kidney Disease (CKD) Treatment Market Size by Country (2023-2028)
9.4 Mexico
9.5 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Chronic Kidney Disease (CKD) Treatment Market Size (2017-2028)
10.2 Middle East & Africa Chronic Kidney Disease (CKD) Treatment Market Size by Country (2017-2022)
10.3 Middle East & Africa Chronic Kidney Disease (CKD) Treatment Market Size by Country (2023-2028)
10.4 Turkey
10.5 Saudi Arabia
10.6 UAE
11 Key Players Profiles
11.1 Fresenius
11.1.1 Fresenius Company Detail
11.1.2 Fresenius Business Overview
11.1.3 Fresenius Chronic Kidney Disease (CKD) Treatment Introduction
11.1.4 Fresenius Revenue in Chronic Kidney Disease (CKD) Treatment Business (2017-2022)
11.1.5 Fresenius Recent Development
11.2 DaVita
11.2.1 DaVita Company Detail
11.2.2 DaVita Business Overview
11.2.3 DaVita Chronic Kidney Disease (CKD) Treatment Introduction
11.2.4 DaVita Revenue in Chronic Kidney Disease (CKD) Treatment Business (2017-2022)
11.2.5 DaVita Recent Development
11.3 Baxter
11.3.1 Baxter Company Detail
11.3.2 Baxter Business Overview
11.3.3 Baxter Chronic Kidney Disease (CKD) Treatment Introduction
11.3.4 Baxter Revenue in Chronic Kidney Disease (CKD) Treatment Business (2017-2022)
11.3.5 Baxter Recent Development
11.4 Nipro
11.4.1 Nipro Company Detail
11.4.2 Nipro Business Overview
11.4.3 Nipro Chronic Kidney Disease (CKD) Treatment Introduction
11.4.4 Nipro Revenue in Chronic Kidney Disease (CKD) Treatment Business (2017-2022)
11.4.5 Nipro Recent Development
11.5 B. Braun
11.5.1 B. Braun Company Detail
11.5.2 B. Braun Business Overview
11.5.3 B. Braun Chronic Kidney Disease (CKD) Treatment Introduction
11.5.4 B. Braun Revenue in Chronic Kidney Disease (CKD) Treatment Business (2017-2022)
11.5.5 B. Braun Recent Development
11.6 Asahi Kasei
11.6.1 Asahi Kasei Company Detail
11.6.2 Asahi Kasei Business Overview
11.6.3 Asahi Kasei Chronic Kidney Disease (CKD) Treatment Introduction
11.6.4 Asahi Kasei Revenue in Chronic Kidney Disease (CKD) Treatment Business (2017-2022)
11.6.5 Asahi Kasei Recent Development
11.7 Nikkiso
11.7.1 Nikkiso Company Detail
11.7.2 Nikkiso Business Overview
11.7.3 Nikkiso Chronic Kidney Disease (CKD) Treatment Introduction
11.7.4 Nikkiso Revenue in Chronic Kidney Disease (CKD) Treatment Business (2017-2022)
11.7.5 Nikkiso Recent Development
11.8 WEGO
11.8.1 WEGO Company Detail
11.8.2 WEGO Business Overview
11.8.3 WEGO Chronic Kidney Disease (CKD) Treatment Introduction
11.8.4 WEGO Revenue in Chronic Kidney Disease (CKD) Treatment Business (2017-2022)
11.8.5 WEGO Recent Development
11.9 Newsol
11.9.1 Newsol Company Detail
11.9.2 Newsol Business Overview
11.9.3 Newsol Chronic Kidney Disease (CKD) Treatment Introduction
11.9.4 Newsol Revenue in Chronic Kidney Disease (CKD) Treatment Business (2017-2022)
11.9.5 Newsol Recent Development
11.10 Mayo Clinic
11.10.1 Mayo Clinic Company Detail
11.10.2 Mayo Clinic Business Overview
11.10.3 Mayo Clinic Chronic Kidney Disease (CKD) Treatment Introduction
11.10.4 Mayo Clinic Revenue in Chronic Kidney Disease (CKD) Treatment Business (2017-2022)
11.10.5 Mayo Clinic Recent Development
11.11 Guangdong Biolight
11.11.1 Guangdong Biolight Company Detail
11.11.2 Guangdong Biolight Business Overview
11.11.3 Guangdong Biolight Chronic Kidney Disease (CKD) Treatment Introduction
11.11.4 Guangdong Biolight Revenue in Chronic Kidney Disease (CKD) Treatment Business (2017-2022)
11.11.5 Guangdong Biolight Recent Development
11.12 Medtronic
11.12.1 Medtronic Company Detail
11.12.2 Medtronic Business Overview
11.12.3 Medtronic Chronic Kidney Disease (CKD) Treatment Introduction
11.12.4 Medtronic Revenue in Chronic Kidney Disease (CKD) Treatment Business (2017-2022)
11.12.5 Medtronic Recent Development
11.13 Sanxin Medtec
11.13.1 Sanxin Medtec Company Detail
11.13.2 Sanxin Medtec Business Overview
11.13.3 Sanxin Medtec Chronic Kidney Disease (CKD) Treatment Introduction
11.13.4 Sanxin Medtec Revenue in Chronic Kidney Disease (CKD) Treatment Business (2017-2022)
11.13.5 Sanxin Medtec Recent Development
11.14 Jafron Biomedical
11.14.1 Jafron Biomedical Company Detail
11.14.2 Jafron Biomedical Business Overview
11.14.3 Jafron Biomedical Chronic Kidney Disease (CKD) Treatment Introduction
11.14.4 Jafron Biomedical Revenue in Chronic Kidney Disease (CKD) Treatment Business (2017-2022)
11.14.5 Jafron Biomedical Recent Development
11.15 SWS Hemodialysis Care
11.15.1 SWS Hemodialysis Care Company Detail
11.15.2 SWS Hemodialysis Care Business Overview
11.15.3 SWS Hemodialysis Care Chronic Kidney Disease (CKD) Treatment Introduction
11.15.4 SWS Hemodialysis Care Revenue in Chronic Kidney Disease (CKD) Treatment Business (2017-2022)
11.15.5 SWS Hemodialysis Care Recent Development
11.16 Tianyi Medical
11.16.1 Tianyi Medical Company Detail
11.16.2 Tianyi Medical Business Overview
11.16.3 Tianyi Medical Chronic Kidney Disease (CKD) Treatment Introduction
11.16.4 Tianyi Medical Revenue in Chronic Kidney Disease (CKD) Treatment Business (2017-2022)
11.16.5 Tianyi Medical Recent Development
11.17 AstraZeneca
11.17.1 AstraZeneca Company Detail
11.17.2 AstraZeneca Business Overview
11.17.3 AstraZeneca Chronic Kidney Disease (CKD) Treatment Introduction
11.17.4 AstraZeneca Revenue in Chronic Kidney Disease (CKD) Treatment Business (2017-2022)
11.17.5 AstraZeneca Recent Development
11.18 Vifor Pharma
11.18.1 Vifor Pharma Company Detail
11.18.2 Vifor Pharma Business Overview
11.18.3 Vifor Pharma Chronic Kidney Disease (CKD) Treatment Introduction
11.18.4 Vifor Pharma Revenue in Chronic Kidney Disease (CKD) Treatment Business (2017-2022)
11.18.5 Vifor Pharma Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
List of Tables
Table 1. Global Chronic Kidney Disease (CKD) Treatment Market Size Growth Rate by Type (US$ Million): 2017 VS 2021 VS 2028
Table 2. Key Players of Medicine
Table 3. Key Players of Hemodialysis
Table 4. Key Players of Peritoneal Dialysis
Table 5. Key Players of Kidney Transplantation
Table 6. Global Chronic Kidney Disease (CKD) Treatment Market Size Growth by Application (US$ Million): 2017 VS 2021 VS 2028
Table 7. Global Chronic Kidney Disease (CKD) Treatment Market Size by Region (US$ Million): 2017 VS 2021 VS 2028
Table 8. Global Chronic Kidney Disease (CKD) Treatment Market Size by Region (2017-2022) & (US$ Million)
Table 9. Global Chronic Kidney Disease (CKD) Treatment Market Share by Region (2017-2022)
Table 10. Global Chronic Kidney Disease (CKD) Treatment Forecasted Market Size by Region (2023-2028) & (US$ Million)
Table 11. Global Chronic Kidney Disease (CKD) Treatment Market Share by Region (2023-2028)
Table 12. Chronic Kidney Disease (CKD) Treatment Market Trends
Table 13. Chronic Kidney Disease (CKD) Treatment Market Drivers
Table 14. Chronic Kidney Disease (CKD) Treatment Market Challenges
Table 15. Chronic Kidney Disease (CKD) Treatment Market Restraints
Table 16. Global Chronic Kidney Disease (CKD) Treatment Revenue by Players (2017-2022) & (US$ Million)
Table 17. Global Chronic Kidney Disease (CKD) Treatment Market Share by Players (2017-2022)
Table 18. Global Top Chronic Kidney Disease (CKD) Treatment Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Chronic Kidney Disease (CKD) Treatment as of 2021)
Table 19. Ranking of Global Top Chronic Kidney Disease (CKD) Treatment Companies by Revenue (US$ Million) in 2021
Table 20. Global 5 Largest Players Market Share by Chronic Kidney Disease (CKD) Treatment Revenue (CR5 and HHI) & (2017-2022)
Table 21. Key Players Headquarters and Area Served
Table 22. Key Players Chronic Kidney Disease (CKD) Treatment Product Solution and Service
Table 23. Date of Enter into Chronic Kidney Disease (CKD) Treatment Market
Table 24. Mergers & Acquisitions, Expansion Plans
Table 25. Global Chronic Kidney Disease (CKD) Treatment Market Size by Type (2017-2022) & (US$ Million)
Table 26. Global Chronic Kidney Disease (CKD) Treatment Revenue Market Share by Type (2017-2022)
Table 27. Global Chronic Kidney Disease (CKD) Treatment Forecasted Market Size by Type (2023-2028) & (US$ Million)
Table 28. Global Chronic Kidney Disease (CKD) Treatment Revenue Market Share by Type (2023-2028)
Table 29. Global Chronic Kidney Disease (CKD) Treatment Market Size by Application (2017-2022) & (US$ Million)
Table 30. Global Chronic Kidney Disease (CKD) Treatment Revenue Market Share by Application (2017-2022)
Table 31. Global Chronic Kidney Disease (CKD) Treatment Forecasted Market Size by Application (2023-2028) & (US$ Million)
Table 32. Global Chronic Kidney Disease (CKD) Treatment Revenue Market Share by Application (2023-2028)
Table 33. North America Chronic Kidney Disease (CKD) Treatment Market Size by Country (2017-2022) & (US$ Million)
Table 34. North America Chronic Kidney Disease (CKD) Treatment Market Size by Country (2023-2028) & (US$ Million)
Table 35. Europe Chronic Kidney Disease (CKD) Treatment Market Size by Country (2017-2022) & (US$ Million)
Table 36. Europe Chronic Kidney Disease (CKD) Treatment Market Size by Country (2023-2028) & (US$ Million)
Table 37. Asia-Pacific Chronic Kidney Disease (CKD) Treatment Market Size by Region (2017-2022) & (US$ Million)
Table 38. Asia-Pacific Chronic Kidney Disease (CKD) Treatment Market Size by Region (2023-2028) & (US$ Million)
Table 39. Latin America Chronic Kidney Disease (CKD) Treatment Market Size by Country (2017-2022) & (US$ Million)
Table 40. Latin America Chronic Kidney Disease (CKD) Treatment Market Size by Country (2023-2028) & (US$ Million)
Table 41. Middle East & Africa Chronic Kidney Disease (CKD) Treatment Market Size by Country (2017-2022) & (US$ Million)
Table 42. Middle East & Africa Chronic Kidney Disease (CKD) Treatment Market Size by Country (2023-2028) & (US$ Million)
Table 43. Fresenius Company Detail
Table 44. Fresenius Business Overview
Table 45. Fresenius Chronic Kidney Disease (CKD) Treatment Product
Table 46. Fresenius Revenue in Chronic Kidney Disease (CKD) Treatment Business (2017-2022) & (US$ Million)
Table 47. Fresenius Recent Development
Table 48. DaVita Company Detail
Table 49. DaVita Business Overview
Table 50. DaVita Chronic Kidney Disease (CKD) Treatment Product
Table 51. DaVita Revenue in Chronic Kidney Disease (CKD) Treatment Business (2017-2022) & (US$ Million)
Table 52. DaVita Recent Development
Table 53. Baxter Company Detail
Table 54. Baxter Business Overview
Table 55. Baxter Chronic Kidney Disease (CKD) Treatment Product
Table 56. Baxter Revenue in Chronic Kidney Disease (CKD) Treatment Business (2017-2022) & (US$ Million)
Table 57. Baxter Recent Development
Table 58. Nipro Company Detail
Table 59. Nipro Business Overview
Table 60. Nipro Chronic Kidney Disease (CKD) Treatment Product
Table 61. Nipro Revenue in Chronic Kidney Disease (CKD) Treatment Business (2017-2022) & (US$ Million)
Table 62. Nipro Recent Development
Table 63. B. Braun Company Detail
Table 64. B. Braun Business Overview
Table 65. B. Braun Chronic Kidney Disease (CKD) Treatment Product
Table 66. B. Braun Revenue in Chronic Kidney Disease (CKD) Treatment Business (2017-2022) & (US$ Million)
Table 67. B. Braun Recent Development
Table 68. Asahi Kasei Company Detail
Table 69. Asahi Kasei Business Overview
Table 70. Asahi Kasei Chronic Kidney Disease (CKD) Treatment Product
Table 71. Asahi Kasei Revenue in Chronic Kidney Disease (CKD) Treatment Business (2017-2022) & (US$ Million)
Table 72. Asahi Kasei Recent Development
Table 73. Nikkiso Company Detail
Table 74. Nikkiso Business Overview
Table 75. Nikkiso Chronic Kidney Disease (CKD) Treatment Product
Table 76. Nikkiso Revenue in Chronic Kidney Disease (CKD) Treatment Business (2017-2022) & (US$ Million)
Table 77. Nikkiso Recent Development
Table 78. WEGO Company Detail
Table 79. WEGO Business Overview
Table 80. WEGO Chronic Kidney Disease (CKD) Treatment Product
Table 81. WEGO Revenue in Chronic Kidney Disease (CKD) Treatment Business (2017-2022) & (US$ Million)
Table 82. WEGO Recent Development
Table 83. Newsol Company Detail
Table 84. Newsol Business Overview
Table 85. Newsol Chronic Kidney Disease (CKD) Treatment Product
Table 86. Newsol Revenue in Chronic Kidney Disease (CKD) Treatment Business (2017-2022) & (US$ Million)
Table 87. Newsol Recent Development
Table 88. Mayo Clinic Company Detail
Table 89. Mayo Clinic Business Overview
Table 90. Mayo Clinic Chronic Kidney Disease (CKD) Treatment Product
Table 91. Mayo Clinic Revenue in Chronic Kidney Disease (CKD) Treatment Business (2017-2022) & (US$ Million)
Table 92. Mayo Clinic Recent Development
Table 93. Guangdong Biolight Company Detail
Table 94. Guangdong Biolight Business Overview
Table 95. Guangdong Biolight Chronic Kidney Disease (CKD) TreatmentProduct
Table 96. Guangdong Biolight Revenue in Chronic Kidney Disease (CKD) Treatment Business (2017-2022) & (US$ Million)
Table 97. Guangdong Biolight Recent Development
Table 98. Medtronic Company Detail
Table 99. Medtronic Business Overview
Table 100. Medtronic Chronic Kidney Disease (CKD) TreatmentProduct
Table 101. Medtronic Revenue in Chronic Kidney Disease (CKD) Treatment Business (2017-2022) & (US$ Million)
Table 102. Medtronic Recent Development
Table 103. Sanxin Medtec Company Detail
Table 104. Sanxin Medtec Business Overview
Table 105. Sanxin Medtec Chronic Kidney Disease (CKD) TreatmentProduct
Table 106. Sanxin Medtec Revenue in Chronic Kidney Disease (CKD) Treatment Business (2017-2022) & (US$ Million)
Table 107. Sanxin Medtec Recent Development
Table 108. Jafron Biomedical Company Detail
Table 109. Jafron Biomedical Business Overview
Table 110. Jafron Biomedical Chronic Kidney Disease (CKD) TreatmentProduct
Table 111. Jafron Biomedical Revenue in Chronic Kidney Disease (CKD) Treatment Business (2017-2022) & (US$ Million)
Table 112. Jafron Biomedical Recent Development
Table 113. SWS Hemodialysis Care Company Detail
Table 114. SWS Hemodialysis Care Business Overview
Table 115. SWS Hemodialysis Care Chronic Kidney Disease (CKD) TreatmentProduct
Table 116. SWS Hemodialysis Care Revenue in Chronic Kidney Disease (CKD) Treatment Business (2017-2022) & (US$ Million)
Table 117. SWS Hemodialysis Care Recent Development
Table 118. Tianyi Medical Company Detail
Table 119. Tianyi Medical Business Overview
Table 120. Tianyi Medical Chronic Kidney Disease (CKD) TreatmentProduct
Table 121. Tianyi Medical Revenue in Chronic Kidney Disease (CKD) Treatment Business (2017-2022) & (US$ Million)
Table 122. Tianyi Medical Recent Development
Table 123. AstraZeneca Company Detail
Table 124. AstraZeneca Business Overview
Table 125. AstraZeneca Chronic Kidney Disease (CKD) TreatmentProduct
Table 126. AstraZeneca Revenue in Chronic Kidney Disease (CKD) Treatment Business (2017-2022) & (US$ Million)
Table 127. AstraZeneca Recent Development
Table 128. Vifor Pharma Company Detail
Table 129. Vifor Pharma Business Overview
Table 130. Vifor Pharma Chronic Kidney Disease (CKD) TreatmentProduct
Table 131. Vifor Pharma Revenue in Chronic Kidney Disease (CKD) Treatment Business (2017-2022) & (US$ Million)
Table 132. Vifor Pharma Recent Development
Table 133. Research Programs/Design for This Report
Table 134. Key Data Information from Secondary Sources
Table 135. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Chronic Kidney Disease (CKD) Treatment Market Share by Type: 2021 VS 2028
Figure 2. Medicine Features
Figure 3. Hemodialysis Features
Figure 4. Peritoneal Dialysis Features
Figure 5. Kidney Transplantation Features
Figure 6. Global Chronic Kidney Disease (CKD) Treatment Market Share by Application in 2021 & 2028
Figure 7. Hospitals Case Studies
Figure 8. Kidney Dialysis Centers Case Studies
Figure 9. At Homes Case Studies
Figure 10. Others Case Studies
Figure 11. Chronic Kidney Disease (CKD) Treatment Report Years Considered
Figure 12. Global Chronic Kidney Disease (CKD) Treatment Market Size (US$ Million), Year-over-Year: 2017-2028
Figure 13. Global Chronic Kidney Disease (CKD) Treatment Market Size, (US$ Million), 2017 VS 2021 VS 2028
Figure 14. Global Chronic Kidney Disease (CKD) Treatment Market Share by Region: 2021 VS 2028
Figure 15. Global Chronic Kidney Disease (CKD) Treatment Market Share by Players in 2021
Figure 16. Global Top Chronic Kidney Disease (CKD) Treatment Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Chronic Kidney Disease (CKD) Treatment as of 2021)
Figure 17. The Top 10 and 5 Players Market Share by Chronic Kidney Disease (CKD) Treatment Revenue in 2021
Figure 18. North America Chronic Kidney Disease (CKD) Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 19. North America Chronic Kidney Disease (CKD) Treatment Market Share by Country (2017-2028)
Figure 20. United States Chronic Kidney Disease (CKD) Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 21. Canada Chronic Kidney Disease (CKD) Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 22. Europe Chronic Kidney Disease (CKD) Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 23. Europe Chronic Kidney Disease (CKD) Treatment Market Share by Country (2017-2028)
Figure 24. Germany Chronic Kidney Disease (CKD) Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 25. France Chronic Kidney Disease (CKD) Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 26. U.K. Chronic Kidney Disease (CKD) Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 27. Italy Chronic Kidney Disease (CKD) Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 28. Russia Chronic Kidney Disease (CKD) Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 29. Nordic Countries Chronic Kidney Disease (CKD) Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 30. Asia-Pacific Chronic Kidney Disease (CKD) Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 31. Asia-Pacific Chronic Kidney Disease (CKD) Treatment Market Share by Region (2017-2028)
Figure 32. China Chronic Kidney Disease (CKD) Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 33. Japan Chronic Kidney Disease (CKD) Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 34. South Korea Chronic Kidney Disease (CKD) Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 35. Southeast Asia Chronic Kidney Disease (CKD) Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 36. India Chronic Kidney Disease (CKD) Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 37. Australia Chronic Kidney Disease (CKD) Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 38. Latin America Chronic Kidney Disease (CKD) Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 39. Latin America Chronic Kidney Disease (CKD) Treatment Market Share by Country (2017-2028)
Figure 40. Mexico Chronic Kidney Disease (CKD) Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 41. Brazil Chronic Kidney Disease (CKD) Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 42. Middle East & Africa Chronic Kidney Disease (CKD) Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 43. Middle East & Africa Chronic Kidney Disease (CKD) Treatment Market Share by Country (2017-2028)
Figure 44. Turkey Chronic Kidney Disease (CKD) Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 45. Saudi Arabia Chronic Kidney Disease (CKD) Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 46. Fresenius Revenue Growth Rate in Chronic Kidney Disease (CKD) Treatment Business (2017-2022)
Figure 47. DaVita Revenue Growth Rate in Chronic Kidney Disease (CKD) Treatment Business (2017-2022)
Figure 48. Baxter Revenue Growth Rate in Chronic Kidney Disease (CKD) Treatment Business (2017-2022)
Figure 49. Nipro Revenue Growth Rate in Chronic Kidney Disease (CKD) Treatment Business (2017-2022)
Figure 50. B. Braun Revenue Growth Rate in Chronic Kidney Disease (CKD) Treatment Business (2017-2022)
Figure 51. Asahi Kasei Revenue Growth Rate in Chronic Kidney Disease (CKD) Treatment Business (2017-2022)
Figure 52. Nikkiso Revenue Growth Rate in Chronic Kidney Disease (CKD) Treatment Business (2017-2022)
Figure 53. WEGO Revenue Growth Rate in Chronic Kidney Disease (CKD) Treatment Business (2017-2022)
Figure 54. Newsol Revenue Growth Rate in Chronic Kidney Disease (CKD) Treatment Business (2017-2022)
Figure 55. Mayo Clinic Revenue Growth Rate in Chronic Kidney Disease (CKD) Treatment Business (2017-2022)
Figure 56. Guangdong Biolight Revenue Growth Rate in Chronic Kidney Disease (CKD) Treatment Business (2017-2022)
Figure 57. Medtronic Revenue Growth Rate in Chronic Kidney Disease (CKD) Treatment Business (2017-2022)
Figure 58. Sanxin Medtec Revenue Growth Rate in Chronic Kidney Disease (CKD) Treatment Business (2017-2022)
Figure 59. Jafron Biomedical Revenue Growth Rate in Chronic Kidney Disease (CKD) Treatment Business (2017-2022)
Figure 60. SWS Hemodialysis Care Revenue Growth Rate in Chronic Kidney Disease (CKD) Treatment Business (2017-2022)
Figure 61. Tianyi Medical Revenue Growth Rate in Chronic Kidney Disease (CKD) Treatment Business (2017-2022)
Figure 62. AstraZeneca Revenue Growth Rate in Chronic Kidney Disease (CKD) Treatment Business (2017-2022)
Figure 63. Vifor Pharma Revenue Growth Rate in Chronic Kidney Disease (CKD) Treatment Business (2017-2022)
Figure 64. Bottom-up and Top-down Approaches for This Report
Figure 65. Data Triangulation
Figure 66. Key Executives Interviewed
  • Global Public and Personal Safety Industry Research Report, Growth Trends and Competitive Analysis 2023-2029
    Published: 11-Jan-2024        Price: US 5600 Onwards        Pages: 177
    The global Public and Personal Safety Industry market size was US$ 6,398.95 million in 2022 and is forecast to a readjusted size of US$ 18,265.36 million by 2029 with a CAGR of 16.88% during the forecast period 2023-2029. The global key companies of Public and Personal Safety Industry include Hexagon, Motorola Solutions Inc, NEC, Tyler Technologies Inc and Indra Sistemas, accounting for 24.50% market share in terms of revenues in 2022. The market research report offered here is a v......
  • Global Digital Watermark Technology Market Report, History and Forecast 2018-2029
    Published: 11-Jan-2024        Price: US 3350 Onwards        Pages: 118
    The global market for Digital Watermark Technology estimated was at US$ 111.3 million in the year 2022, is projected to reach a revised size of US$ 210.53 million by 2029, growing at a CAGR of 9.4% during the forecast period 2023-2029. North American market for Digital Watermark Technology was valued at $ 39.07 million in 2022 and will reach $ 68.79 million by 2029, at a CAGR of 8.2 % during the forecast period of 2023 through 2029. Asia-Pacific market for Digital Watermark Technol......
  • Global Location Based Marketing Services Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 74
    The global Location Based Marketing Services market was valued at US$ 46700 million in 2023 and is anticipated to reach US$ 144870 million by 2030, witnessing a CAGR of 17.2% during The forecast period 2024-2030. North American market for Location Based Marketing Services is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Location Based Marketing Services is estima......
  • Global Auto Repair and Beauty Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 72
    The global Auto Repair and Beauty market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. Automotive is a key driver of this industry. According to data from The World Automobile Organization (OICA), global automobile production and sales in 2017 reached their peak in The past 10 years, at 97.3 million and 95.89 million respectively. In 2018, The global economic expansion ended, and The gl......
  • Global Viral Vector Development Service Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 77
    The global Viral Vector Development Service market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Viral Vector Development Service is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Viral Vector Development Service is estimated to increase from......
  • Global Building Automation Systems (BAS) Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 85
    The global Building Automation Systems (BAS) market was valued at US$ 75680 million in 2023 and is anticipated to reach US$ 143970 million by 2030, witnessing a CAGR of 9.5% during The forecast period 2024-2030. North American market for Building Automation Systems (BAS) is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Building Automation Systems (BAS) is estimat......
  • Global SLAM in Mobile Robots and Smart AR Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 92
    This report studies The SLAM Robots market, Simultaneous localization and mapping, or SLAM for short, is The process of creating a map using a robot or unmanned vehicle that navigates that environment while using The map it generates. SLAM is technique behind robot mapping or robotic cartography. The robot or vehicle plots a course in an area, but at The same time, it also has to figure out where its own self is located in The place. The process of SLAM uses a complex array of computations, algo......
  • Global Digital Educational Publishing Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 90
    The global Digital Educational Publishing market was valued at US$ 8324.5 million in 2023 and is anticipated to reach US$ 14580 million by 2030, witnessing a CAGR of 7.9% during The forecast period 2024-2030. North American market for Digital Educational Publishing is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Digital Educational Publishing is estimated to inc......
  • Global Human Source Service Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 70
    The global Human Source Service market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Human Source Service is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Human Source Service is estimated to increase from $ million in 2023 to reach $ millio......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs